In the News
-
Tessa Therapeutics announces results from two independent phase I/II trials of autologous CD30 CAR-T cell therapy in patients with relapsed or...Article -
Dr Davidson, a lipidology expert, joins the board at CaladriusArticle -
Kite Becomes the First Company with Multiple Approved CAR T TherapiesArticle -
New state-of-the-art centre to scale up COVID-19 vaccine and gene therapy manufacturing gets £100m investmentArticle -
Leading-edge, comprehensive electronic format master files for IL-2, IL-7, IL-15, and IL-21 provide transparency and regulatory support for cell and...Article -
An update on Phacilitate's rebrand activitiesArticle -
Details of the agreement between Moderna and CatalentArticle -
A statement on the future of the World Stem Cell Summit and Phacilitate's Advanced Therapies Week 2021Article -
Cobra Biologics is providing large scale manufacturing capacity for AZD1222Article -
The collaboration will see Achilles Therapeutics expand their manufacturing footprint at the CGT Catapult manufacturing centre to supply clinical...Article -
Alligator Bioscience and Scandion Oncology collaborate on combination therapy to treat previously resistant cancer cellsArticle -
CCRM and Cytiva, formerly part of GE Healthcare Life Sciences, renew collaboration agreement for Centre for Advanced Therapeutic Cell TechnologiesArticle -
Data completion process is nearing the finish lineArticle -
Oxford Biomedica and AstraZeneca agree partnership to manufacture Covid-19 vaccine candidateArticle -
World-class platform will enable biotechnology companies and researchers to accelerate the development, manufacturing and release of cell and gene...Article -
The companies will combine their expertise to explore novel methods to characterise pluripotent stem cells for the manufacture of regenerative...Article -
The collaboration will leverage Avectas’ cell engineering technology and ONKs Death Receptor TRAIL variantArticle -
CCRM and GE Healthcare Life Sciences develop proprietary media formulations for Platelet BioGenesisArticle -
HemaCare launch new GMP-compliant bone marrow starting materialArticle -
Phacilitate's new initiative, Advanced Therapies Week incorporates Phacilitate Leaders World, the World Stem Cell Summit and a brand new creative...Article -
Transformative acquisition creates global cell and gene therapy manufacturing services platform for both clinical and commercial productsArticle -
An expansion of advanced therapies manufacturing capacity in the European marketArticle -
EQT to partner with founder and CEO Michael Chambers, as well as TA Associates, to support Aldevron on its future growth journeyArticle -
Medace will be moving to Brightlands Maastricht Health Campus in January 2020 where it will reside in a brand new, state of the art GMP-ready...Article -
New rocking motion single-use bioreactor system to culture cell products in working volumes up to 5 L and Flexsafe® RM TX bags premier at...Article -
EXELLULA, the new Italian industrial complex entirely dedicated to the production of cell and gene therapies, will be a centre of excellence for...Article -
Novel Packaging and Expression Plasmids Promise to Reduce Gene Therapy Manufacturing Costs and Delivery TimesArticle -
FloDesign Sonics announce the commercial launch of their first product within the ekko platform line to support the needs of cell and gene therapy...Article -
Clinical trials around adipose-derived regenerative cells focus of programArticle -
Anemocyte sponsor Phacilitate:TALKS, a new stage at Phacilitate Leaders World 2019Article -
VIVEbiotech receives the Technological Innovation SME Award at the Pyme Awards in Madrid, SpainArticle -
A brand new partnership between the Emily Whitehead Foundation and PhacilitateArticle -
State-of-the-art facility to meet industry demand for high-quality GMP cellular materialArticle -
Press release from Vineti, Inc.Article
